Adverse Events in Acute Limb Ischemic Patient Undergoing Revascularization

Last updated: May 3, 2022
Sponsor: Mahidol University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05362266
052/2565
  • Ages 18-90
  • All Genders

Study Summary

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age more than 18 years
  • undergoing revascularization surgery or procedure (surgical revascularization,endovascular revascularization, hybrid revascularization, catheter directedthrombolysis)

Exclusion

Exclusion Criteria:

  • incomplete data during perioperative period

Study Design

Total Participants: 240
Study Start date:
April 10, 2022
Estimated Completion Date:
April 01, 2023

Connect with a study center

  • Anesthesiology department, Siriraj Hospital, Mahidol University

    Bangkok,
    Thailand

    Active - Recruiting

  • MahidolU

    Bangkok,
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.